Publish Ahead of Print

Editorial Commentary

Management of glioblastoma: a perspective from Lithuania
Adomas Bunevicius, Jurgita Usinskiene, Inesa Buneviciene, Ieva Vincerzevskiene
Real-world applications of deep convolutional neural networks in diagnostic cancer imaging
Hesham Elhalawani, Pei Yang, Mohamed Abazeed, Chirag Shah, Abdallah S. R. Mohamed, Charles R. Thomas Jr, Clifton D. Fuller, Reid F. Thompson
Immunotherapy in lung cancer: the chemotherapy conundrum
Laxmi Narayana R. Buddharaju, Apar Kishor Ganti
Global burden of childhood and adolescent cancer
Emma R. Woodward, D. Gareth Evans
Moving toward multi-dimensional biomarkers in cancer immunotherapy
Max Jameson-Lee, Jason J. Luke
The prognostic nomogram in platinum-resistant ovarian cancer: how to develop and validate?
Kuo-Chang Wen, Pi-Lin Sung, Hung-Cheng Lai
The role of ramucirumab and pembrolizumab combination in patients with advanced non-small cell lung cancer, gastroesophageal adenocarcinoma, or urothelial carcinoma
Jane E. Rogers, Jaffer A. Ajani
Indolent non-Hodgkin lymphoma treatment in the new drugs era
Luis Miguel Juárez-Salcedo, Samir Dalia
PD-L1 expression and efficacy of pembrolizumab as monotherapy in NSCLC
Jan Trøst Jørgensen
REACH-2: first biomarker-based anti-angiogenic therapy in patients with advanced hepatocellular carcinoma
Hong Jae Chon, Chan Kim
Management of glioblastoma: an Australian perspective
Hao-Wen Sim, Anna K. Nowak, Zarnie Lwin, Mustafa Khasraw
Management of glioblastoma: a perspective from Nigeria
James A. Balogun, Adefisayo A. Adekanmbi
Analysis of the association between adverse events and outcome in patients receiving a programmed death protein-1 or programmed death ligand-1 antibody
Marilina García-Aranda, Maximino Redondo
Ramucirumab treatment in hepatocellular carcinoma
Federico Longo, Alfredo Carrato

Original Article

Outcomes of adjuvant whole-brain radiotherapy versus hypofractionated stereotactic radiotherapy after surgical resection of brain metastases: a propensity score-matched analysis
Audrey Keller, François Lefebvre, Damien Ricard, Georges Noël, Delphine Antoni
Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dual-institutional analysis
Jonathan G. Sham, Shiwei Guo, Ding Ding, Zhuo Shao, Michael Wright, Wei Jing, Ling-Di Yin, Yijie Zhang, Michele M. Gage, Yingqi Zhou, Ammar Javed, Richard A. Burkhart, Xuyu Zhou, Matthew J. Weiss, Tianlin He, Gang Li, John L. Cameron, Xiangui Hu, Christopher L. Wolfgang, Gang Jin, Jin He

Review Article

Controversies on the treatment of ovarian cancer with dose-dense chemotherapy
Alberto Súarez-Zaizar, Eduardo Cárdenas-Cárdenas, Yadira Araceli Barajas-Castro, Patricia Cortés-Esteban
Systemic therapy for non-serous ovarian carcinoma
Yanin Chávarri-Guerra, Eduardo González-Ochoa, Héctor De-la-Mora-Molina, Enrique Soto-Perez-de-Celis
Management of glioblastoma: a perspective from Mexico
Sergio Moreno-Jiménez, Marco A. Alegría-Loyola, Adam M. Sonabend, Sofia K. Romano, Carlos G. Romo
Liver-directed therapy for hepatocellular carcinoma
Cathal O’Leary, Mary Mahler, Michael C. Soulen
Anti-angiogenic therapies in the management of glioblastoma
Jessica D. Schulte, Manish K. Aghi, Jennie W. Taylor
Epidemiology of ovarian cancer
Patricia Gaona-Luviano, Lourdes Adriana Medina-Gaona, Kassandra Magaña-Pérez
The optimal timing and management of hepatitis B and C in patients with hepatocellular carcinoma
Thuy-Van P. Hang, Joel P. Wedd
Target treatment with stereotactic radiation for recurrent gliomas
Ayesha S. Ali, Victor E. Chen, Claire Zurlo, James M. Taylor, Christian Fernandez, Wenyin Shi
Role of hyperthermic intraperitoneal chemotherapy in ovarian cancer
Juan Manuel Medina-Castro, Adriana Ruiz-DeLeón
Can lymphadenectomy be omitted in advanced ovarian cancer? A brief review
Rosa A. Salcedo-Hernández
Fertility-sparing treatment for epithelial ovarian cancer: a literature review
Milagros Pérez-Quintanilla, Sarish del Real-Ordoñez, Lenny Gallardo-Alvarado, David Cantu-de Leon
Imaging diagnosis of hepatocellular carcinoma: LI-RADS
Guilherme Moura Cunha, Claude B. Sirlin, Kathryn J. Fowler
Surgical resection of early stage hepatocellular carcinoma: balancing tumor biology with the host liver
Michelle R. Ju, Adam C. Yopp
Radiotherapy in women with epithelial ovarian cancer: historical role, current advances, and indications
Christian Haydeé Flores-Balcázar, Dulce María Urías-Arce
Non-epithelial ovarian carcinoma: what is the optimal staging surgery?
Heriberto Medina-Franco, Luis Enrique Colonna-Márquez
Systemic therapy for advanced hepatocellular carcinoma: targeted therapies
Sri Harsha Tella, Anuhya Kommalapati, Amit Mahipal
Hepatocellular carcinoma, novel therapies on the horizon
Imane El Dika, Iman Makki, Ghassan K. Abou-Alfa
Ovarian carcinoma: pathology review with an emphasis in their molecular characteristics
Leonardo S. Lino-Silva
Efficacy and safety of radiotherapy for primary liver cancer
Wenqi Chen, Chi-Leung Chiang, Laura A. Dawson
Tumor treating fields in neuro-oncology: integration of alternating electric fields therapy into promising treatment strategies
Tamar R. Berger, Eric T. Wong
A view of the epidemiologic landscape: how population-based studies can lend novel insights regarding the pathophysiology of glioblastoma
Ramya Tadipatri, Kristopher Lyon, Amir Azadi, Ekokobe Fonkem